– Nearly 1,000 people with advanced Parkinson's disease in the UK will benefit from the new treatment Produodopa, provided by NHS England.
Patients receive the infusion through a cannula under the skin, controlled by an automatic pump that releases medication 24 hours a day
NHS England's medical director for specialised services, James Palmer, highlights the significance of the drug's availability
– Many current Parkinson's patients rely on over 20 pills daily, facing inconsistent symptom control, which can worsen throughout the day and night.
Patients involved in clinical trials express positive experiences with the new treatment, citing improved symptom management and quality of life
Parkinson's UK acknowledges Produodopa as a potential "life-changing option" for some patients, emphasizing the importance of consulting healthcare professionals